Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Robb

Showing results (461-470 of 731) with videos related to

Pageof 74
Sort By:
Journal of Neurovirology|January 29, 2020
Resting-state neural signatures of depressive symptoms in acute HIVCarissa L Philippi, Leah Reyna, Laura Nedderman, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infectionJ H Kim, J R Mascola, S Ratto-Kim, et al.
JCI Insight|May 18, 2018
Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir sizeJeffrey E Teigler, Louise Leyre, Nicolas Chomont, et al.
Tissue Antigens|March 4, 2009
HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic clusterG H Kijak, A M Walsh, R N Koehler, et al.
Plos One|September 28, 2011
A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cellsMichael A Eller, Bonnie M Slike, Josephine H Cox, et al.
Immunogenetics|April 1, 2014
HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trialHeather A Prentice, Philip K Ehrenberg, Karen M Baldwin, et al.
The Journal of Infectious Diseases|August 31, 2018
Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected KenyansAndrew Letizia, Michael A Eller, Christina Polyak, et al.
The Journal of Infectious Diseases|October 7, 2010
Class I HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, TanzaniaRebecca N Koehler, Anne M Walsh, Elmar Saathoff, et al.
Journal of Virology|April 10, 1999
Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodiesJ R Mascola, M G Lewis, G Stiegler, et al.
Frontiers in Immunology|May 16, 2020
Induction of Identical IgG HIV-1 Envelope Epitope Recognition Patterns After Initial HIVIS-DNA/MVA-CMDR Immunization and a Late MVA-CMDR BoostAgricola Joachim, Mohamed I M Ahmed, Georgios Pollakis, et al.
Pageof 74

Showing results (461-470 of 731) with videos related to

Sort By:
Pageof 74
Journal of Neurovirology|January 29, 2020
Resting-state neural signatures of depressive symptoms in acute HIVCarissa L Philippi, Leah Reyna, Laura Nedderman, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infectionJ H Kim, J R Mascola, S Ratto-Kim, et al.
JCI Insight|May 18, 2018
Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir sizeJeffrey E Teigler, Louise Leyre, Nicolas Chomont, et al.
Tissue Antigens|March 4, 2009
HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic clusterG H Kijak, A M Walsh, R N Koehler, et al.
Plos One|September 28, 2011
A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cellsMichael A Eller, Bonnie M Slike, Josephine H Cox, et al.
Immunogenetics|April 1, 2014
HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trialHeather A Prentice, Philip K Ehrenberg, Karen M Baldwin, et al.
The Journal of Infectious Diseases|August 31, 2018
Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected KenyansAndrew Letizia, Michael A Eller, Christina Polyak, et al.
The Journal of Infectious Diseases|October 7, 2010
Class I HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, TanzaniaRebecca N Koehler, Anne M Walsh, Elmar Saathoff, et al.
Journal of Virology|April 10, 1999
Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodiesJ R Mascola, M G Lewis, G Stiegler, et al.
Frontiers in Immunology|May 16, 2020
Induction of Identical IgG HIV-1 Envelope Epitope Recognition Patterns After Initial HIVIS-DNA/MVA-CMDR Immunization and a Late MVA-CMDR BoostAgricola Joachim, Mohamed I M Ahmed, Georgios Pollakis, et al.
Pageof 74